vTv Therapeutics VTVT Cash Flow Statement (2014-2026)

NASDAQ VTVT
$33.35 -0.12 (-0.36%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

vTv Therapeutics Quarterly Cash Flow Statement

Periods 49 quarters
Latest Jun 2026

vTv Therapeutics reported cash from operations of -$11.44M and free cash flow of -$11.44M for the quarter ended Jun 2026, down 124.6% year over year. This cash flow statement covers 49 quarters of results from Jun 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.47M-9.48M-9.42M-4.09M-5.47M-6.09M-5.77M-7.21M-8.54M-4.44M-6.02M-6.41M-5.84M-4.44M-6.22M-7.38M-10.35M-7.14M24.13M-13.05M
Share-based Compensation
4.47M0.99M5.72M0.17M0.34M0.29M0.34M0.40M0.43M0.40M0.22M0.86M0.85M0.82M0.81M0.93M1.01M1.02M1.39M1.73M
Gains from Investment Securities
-0.34M-0.17M0.37M-0.12M-0.08M-0.33M0.03M-0.05M0.07M0.07M-0.02M-0.04M
Cash from Operations
-3.59M-6.42M-1.02M0.71M-8.83M-6.88M-5.17M-6.17M-4.83M-2.91M-7.33M-6.73M-6.42M-4.83M-5.69M-5.09M-5.22M-9.25M9.15M-11.44M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
Amortization of Deferred Charges
Change in Working Capital
Change in Receivables
0.93M-0.87M0.02M-0.02M0.12M-0.17M0.10M0.88M-0.68M-0.06M-0.18M
Change in Accured Expenses
-0.21M3.34M4.43M-2.89M-2.95M0.56M1.03M0.74M0.50M0.66M-1.51M-1.94M-0.56M-1.20M-0.84M1.02M4.59M-3.25M0.26M0.17M
Other Working Capital Changes
1.24M0.47M-0.73M-0.69M0.57M1.26M-0.69M-0.52M0.55M-0.89M-0.41M-0.34M0.78M0.18M-0.45M-0.38M0.48M-0.10M-0.22M-0.10M
Investing Activities
Capital Expenditures
-0.10M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.02M
Sales of Property, Plant and Equipment
Cash from Investing Activities
4.40M
Financing Activities
Other financing activities
0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances
0.80M0.26M0.52M0.03M0.22M0.34M0.03M0.19M0.39M
Long-Term Debt Repayments
Short-Term Debt issuances
Change in Capital Stock
Net Shares Issued and Repurchased
3.37M2.53M
Net Equity Issued and Repurchased
17.00M0.65M-5.04M
Misc.
Cash from Financing Activities
12.32M0.27M-0.26M5.04M6.30M3.67M11.81M0.47M-0.28M50.14M2.46M-0.04M77.80M-0.32M
Change in Cash
8.73M-6.15M-1.28M5.72M-2.52M-3.21M6.64M-6.17M-4.36M1.21M42.81M-6.73M-3.96M-4.83M-5.69M-5.14M72.58M-9.57M9.15M-11.44M
Free Cash Flow
-3.59M-6.42M-1.02M0.71M-8.83M-6.88M-5.17M-6.17M-4.83M-2.81M-7.31M-6.70M-6.39M-4.79M-5.65M-5.06M-5.19M-9.23M9.15M-11.44M
Net Cash Flow
8.73M-6.15M-1.28M5.75M-2.52M-3.21M6.64M-6.17M-4.36M1.21M42.81M-6.73M-3.96M-4.83M-5.69M-5.14M72.58M-9.57M9.15M-11.44M